2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
Hatch-Waxman Patent Litigation (Branded)
| Hatch-Waxman Patent Litigation (Branded) — Highly Recommended |
|---|
| Covington & Burling |
| Finnegan Henderson Farabow Garrett & Dunner |
| Fish & Richardson |
| Paul Hastings |
| Sidley Austin |
| Venable |
| Williams & Connolly |
| WilmerHale |
| Hatch-Waxman Patent Litigation (Branded) — Recommended |
|---|
| Arnold & Porter |
| Bartlit Beck |
| Dechert |
| Jones Day |
| Kirkland & Ellis |
| Latham & Watkins |
| Mayer Brown |
| O'Melveny & Myers |
| Quinn Emanuel Urquhart & Sullivan |
Patent Prosecution
Patent Strategy & Management
| Patent Strategy & Management — Recommended |
|---|
| Arnold & Porter |
| Dechert |
| Fenwick & West |
| Foley & Lardner |
| Greenberg Traurig |
| Hamilton Brook Smith & Reynolds |
| Leydig Voit & Mayer |
| McDonnell Boehnen Hulbert & Berghoff |
| Morgan Lewis & Bockius |
| Venable |
| WilmerHale |
Product Liability
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Conde, Dominick A | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Halpern, Todd | Washington, D.C. | ||
| Kallas, Nicholas | Intellectual Property | Hatch-Waxman Patent Litigation | New York City |
| Kline, Steven C | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Marshall, Stephen | Non-IP Litigation & Enforcement | Product Liability | Baltimore |
| Murnane, John D | Intellectual Property | Hatch-Waxman Patent Litigation | New York City |
| Parker, Bruce | Non-IP Litigation & Enforcement | Product Liability | Baltimore |
| Reed, Scott K | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Russo, Alicia | Intellectual Property | Patent Strategy & Management | New York City |
| Schwarz, Christina | Intellectual Property | Hatch-Waxman Patent Litigation | New York |
| Solander, William | Intellectual Property | Hatch-Waxman Patent Litigation | New York City |
| Thompson, Craig | Non-IP Litigation & Enforcement | Product Liability | Baltimore |
| Wong, Ha Kung | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Venable
Venable receives top-tier status in branded Hatch-Waxman litigation and patent prosecution, with additional rankings in general patent litigation and strategy. A peer calls the firm "a force to be reckoned with in Hatch-Waxman."
IP group co-chair Dominick Conde is a leader in the firm's Hatch-Waxman litigation practice with more than 25 years of experience in law. He recently acted for Nalpropion in a Federal Circuit appeal against Actavis, resulting in a favorable ruling for the client. Scott Reed is co-chair of the firm's IP litigation practice group, specializing in pharmaceutical, biotechnology and medical device disputes. Ha Kung Wong specializes in patent and trade secret litigation, often for clients in the pharmaceutical area.
William Solander is a first-chair trial lawyer who recently represented Sanofi in a novel IPR appeal that vacated a decision made by the PTAB. John Murnane's career in patent litigation spans more than 30 years, during which time he has accumulated expertise in district court, ITC, Federal Circuit and post-grant matters. Christina Schwarz and Nicholas Kallas acted for Novartis in a second ANDA litigation against Lupin involving allegedly infringed patents covering Entresto.
For non-contentious work, Alicia Russo is one of the firm's expert patent strategists, advising clients in the biologics and pharmaceutical sectors.
Non-IP Litigation & Enforcement
Venable
Headquartered in Baltimore with an additional seven offices across the country, Venable is a full-service law firm with a significant presence in the life sciences space. In particular, the firm offers a host of litigation services to clients in the industry, including representation in product liability suits and government investigations.
Stephen Marshall is a seasoned litigator who is highly regarded for his expertise in product liability matters. Most notably, Marshall is leading a team that serves as national counsel for Merck in a case involving one of the company's products, Fosamax. In addition, Marshall represents Merck in separate litigation related to its prescription drugs Propecia and Proscar.
Working alongside Marshall in Baltimore on a number of matters is litigation standout Craig Thompson and new star Bruce Parker. Thompson and Parker currently lead the team serving as co-national counsel for Takeda in litigation involving the company's proton-pump inhibitor (PPI) medications, including Prevacid and Dexilant, which plaintiffs allege caused kidney injuries.